Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
good job pastor..many more "starter" positions will be taken here IMO!
IFUS NEWS!
IFUS PR
Impact Fusion International, Inc. Introduces Intact Oral
98% of American Dentists and 91% of American Doctors Believe There Is Link Between Oral Health and Overall Health*
marketwire
*
Share
*
retweet
* Email
* Print
*
Companies:
o Impact Fusion International Inc.
Related Quotes
Symbol Price Change
IFUS.PK 0.0100 +0.0010
Chart for IMPACT FUSION INTL
{"s" : "ifus.pk","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00","o" : "","j" : ""}
Press Release Source: Impact Fusion International On Monday November 8, 2010, 9:18 am
MARGATE, FL--(Marketwire - 11/08/10) - Impact Fusion International, Inc. (Pinksheets:IFUS - News) (The Company) today announced the launching of the latest addition of its Intact Nutrition product line -- Intact Oral (www.intactnutrition.com).
In an article published by the American Dental Association Journal, 2006, entitled "Healthy Mouth, Healthy Body," the importance of maintaining excellent oral hygiene was emphasized as an integral part of our foundation to health and wellness. *(http://www.medicalnewstoday.com/articles/49270.php)
It stated: "The mouth is a window into the health of the body. It can show signs of nutritional deficiencies or general infection... The mouth is filled with countless bacteria, some linked to tooth decay and periodontal (gum) disease."
Nutri-Mastic™, the key ingredient of Intact Oral Health, is a perfect balance of Magnesium, Calcium, Ionic Trace Minerals and the Mediterranean region herb Mastic Gum. Nutri-Mastic supports the oral saliva which is beneficial to one's oral health and the digestive system. While bacteria will always be in our mouths, proper oral care and habits can protect against and reduce the effects of some harmful bacteria. The normal gastrointestinal tract contains the most toxic environment to which most people are ever exposed; from the mouth to the rectum, every centimetre is colonized by bacteria, with the colon bearing the greatest load.
Joseph Scivoletto, President, stated: "We believe that taking Intact Oral as part of your daily dental regime will aid in optimal oral, dental and overall health."
Nutri-Mastic™ supports delivery of nutritional absorption into the cellular system and delivers anti-oxidant and anti-inflammatory properties, supports oral, digestive and immune systems, vital organ health, healthy blood cells, cardiac muscle and heart function. Mastic use and pharmacology activity against several bacterial and fungal pathogens is documented in the scientific literature. Clinical trials document oral antiseptic and antibacterial activity for use in dentistry and digestive health. The above noted report advises that everyone: "Brush your teeth thoroughly twice a day. Clean between your teeth with floss or another type of interdental cleaner once a day. Your dentist may recommend using an antimicrobial mouth rinse as part of your daily oral hygiene routine."
Read More About Intact Nutrition: www.intactnutrition.com
Read More About Nutri-Mastic™: www.intactnutrition.com/nutri-mastic.html
About Impact Fusion International, Inc:
Impact Fusion International, Inc. is in the business of marketing products in the "Health and Wellness" sector of all international markets. It is the company's mission to invent, develop and market these proprietary products worldwide for the health and well-being of humans and animals.
For More Information: Please call 1-877-716-6668 or email: info@impactfusionintl.com.
This release may include projections of future results and "forward-looking statements" as that term is defined in Section 27A of the Securities Act of 1933 as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934 as amended (the "Exchange Act"). All statements that are included in this release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in these forward-looking statements are reasonable; it can give no assurances that such expectations will prove to have been correct. Important factors that could cause actual results to differ materially from the expectations disclosed in this release, including, without limitation, in conjunction with those forward-looking statements contained in this release.
Contact:
Marc Walther
1-877-716-6668
info@impactfusionintl.com
IFUS PR
Impact Fusion International, Inc. Introduces Intact Oral
98% of American Dentists and 91% of American Doctors Believe There Is Link Between Oral Health and Overall Health*
marketwire
*
Share
*
retweet
* Email
* Print
*
Companies:
o Impact Fusion International Inc.
Related Quotes
Symbol Price Change
IFUS.PK 0.0100 +0.0010
Chart for IMPACT FUSION INTL
{"s" : "ifus.pk","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00","o" : "","j" : ""}
Press Release Source: Impact Fusion International On Monday November 8, 2010, 9:18 am
MARGATE, FL--(Marketwire - 11/08/10) - Impact Fusion International, Inc. (Pinksheets:IFUS - News) (The Company) today announced the launching of the latest addition of its Intact Nutrition product line -- Intact Oral (www.intactnutrition.com).
In an article published by the American Dental Association Journal, 2006, entitled "Healthy Mouth, Healthy Body," the importance of maintaining excellent oral hygiene was emphasized as an integral part of our foundation to health and wellness. *(http://www.medicalnewstoday.com/articles/49270.php)
It stated: "The mouth is a window into the health of the body. It can show signs of nutritional deficiencies or general infection... The mouth is filled with countless bacteria, some linked to tooth decay and periodontal (gum) disease."
Nutri-Mastic™, the key ingredient of Intact Oral Health, is a perfect balance of Magnesium, Calcium, Ionic Trace Minerals and the Mediterranean region herb Mastic Gum. Nutri-Mastic supports the oral saliva which is beneficial to one's oral health and the digestive system. While bacteria will always be in our mouths, proper oral care and habits can protect against and reduce the effects of some harmful bacteria. The normal gastrointestinal tract contains the most toxic environment to which most people are ever exposed; from the mouth to the rectum, every centimetre is colonized by bacteria, with the colon bearing the greatest load.
Joseph Scivoletto, President, stated: "We believe that taking Intact Oral as part of your daily dental regime will aid in optimal oral, dental and overall health."
Nutri-Mastic™ supports delivery of nutritional absorption into the cellular system and delivers anti-oxidant and anti-inflammatory properties, supports oral, digestive and immune systems, vital organ health, healthy blood cells, cardiac muscle and heart function. Mastic use and pharmacology activity against several bacterial and fungal pathogens is documented in the scientific literature. Clinical trials document oral antiseptic and antibacterial activity for use in dentistry and digestive health. The above noted report advises that everyone: "Brush your teeth thoroughly twice a day. Clean between your teeth with floss or another type of interdental cleaner once a day. Your dentist may recommend using an antimicrobial mouth rinse as part of your daily oral hygiene routine."
Read More About Intact Nutrition: www.intactnutrition.com
Read More About Nutri-Mastic™: www.intactnutrition.com/nutri-mastic.html
About Impact Fusion International, Inc:
Impact Fusion International, Inc. is in the business of marketing products in the "Health and Wellness" sector of all international markets. It is the company's mission to invent, develop and market these proprietary products worldwide for the health and well-being of humans and animals.
For More Information: Please call 1-877-716-6668 or email: info@impactfusionintl.com.
This release may include projections of future results and "forward-looking statements" as that term is defined in Section 27A of the Securities Act of 1933 as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934 as amended (the "Exchange Act"). All statements that are included in this release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in these forward-looking statements are reasonable; it can give no assurances that such expectations will prove to have been correct. Important factors that could cause actual results to differ materially from the expectations disclosed in this release, including, without limitation, in conjunction with those forward-looking statements contained in this release.
Contact:
Marc Walther
1-877-716-6668
info@impactfusionintl.com
My Pick is IFUS..looking for some good movement today after PR!
i want at least 100k by eod!
I love all the recent headlines Quick18! tons of info to digest...tons of info! i love it
looking good off the dip today..let's keep up the volume and close this baby green
looking to move back to .35 before EOD
definitely think they will spill them beans soon my friend...let's keep this thing moving !
SPPH CASH BUYOUT!
According to the company, a private equity firm has provided the board of directors with an all-cash offer to acquire any and all shares of the company. The board of directors has agreed to keep the offer confidential until an investment bank can be mandated to review the offer, conduct an appropriate due-diligence and recommend a course of action.
"We are surprised to be receiving an all-cash offer at this stage, and in order to keep our shareholders informed , we have opted to announce the receipt of the offer yet until we can have an independent review of the offer we will remain quiet as to his details," said Dr. Arella, President of Spencer Pharmaceutical Inc. "We don't want to alarm our shareholders and or put false hopes that a transaction is imminent so all we can do at this time is continue with the development of our licensing program and further development of our technology and business model to create sustainable shareholder value," further added Dr. Arella.
SPPH CASH BUYOUT!
According to the company, a private equity firm has provided the board of directors with an all-cash offer to acquire any and all shares of the company. The board of directors has agreed to keep the offer confidential until an investment bank can be mandated to review the offer, conduct an appropriate due-diligence and recommend a course of action.
"We are surprised to be receiving an all-cash offer at this stage, and in order to keep our shareholders informed , we have opted to announce the receipt of the offer yet until we can have an independent review of the offer we will remain quiet as to his details," said Dr. Arella, President of Spencer Pharmaceutical Inc. "We don't want to alarm our shareholders and or put false hopes that a transaction is imminent so all we can do at this time is continue with the development of our licensing program and further development of our technology and business model to create sustainable shareholder value," further added Dr. Arella.
According to the company, a private equity firm has provided the board of directors with an all-cash offer to acquire any and all shares of the company. The board of directors has agreed to keep the offer confidential until an investment bank can be mandated to review the offer, conduct an appropriate due-diligence and recommend a course of action.
"We are surprised to be receiving an all-cash offer at this stage, and in order to keep our shareholders informed , we have opted to announce the receipt of the offer yet until we can have an independent review of the offer we will remain quiet as to his details," said Dr. Arella, President of Spencer Pharmaceutical Inc. "We don't want to alarm our shareholders and or put false hopes that a transaction is imminent so all we can do at this time is continue with the development of our licensing program and further development of our technology and business model to create sustainable shareholder value," further added Dr. Arella.
ADD this in for SPPH equation!
http://finance.yahoo.com/news/Spencer-Pharmaceutical-iw-1678745832.html?x=0&.v=1
SPPH-TONS OF NEWS TO REVIEW
http://www.spencerpharmaceutical.com/index.php?pg=quotes&cat=ir
SPPH-TONS OF NEWS TO REVIEW
http://www.spencerpharmaceutical.com/index.php?pg=quotes&cat=ir
cash buyout, people! this is big time!
i think we will see some more volume soon..not to worry
love the strong volume today! let's finish off power hour with some green!
power hour is coming...let's move back to the 6s!
thinking we could see 650k in volume today
bid ask uptick! let's move
i was smart, i grabbed a handful! already green on it
with more info regarding the cash buy out, i think this sees a move to the 50s soon IMO!
got some awesome news today...just amazing how transparent this company is!
we will see price appreciation soon langlui. let the news spread across the penny land, and we will move north!
once they move to BB, i think we get a swarm of new money in here
no doubt..smart money is buying right now for the future
i bought that dip let's move!
super tight float here...we can see this move bigly with some pressure at the ask
let's rocket back to .065 by EOD!
grabbed a few here! too good of a deal IMO!
loading the WMNS dip here
WMNS...loading this dip!
SPPH gets all cash offer for buyout!
HUGE SPPH NEWS
Spencer Pharmaceutical Receives Unsolicited All-Cash Offer
marketwire
*
Share
*
retweet
* Email
* Print
*
Companies:
o Spencer Pharmaceutical Inc.
Related Quotes
Symbol Price Change
SPPH.PK 0.2850 -0.0050
Chart for EMERGENSYS CORP
{"s" : "spph.pk","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00","o" : "","j" : ""}
Press Release Source: Spencer Pharmaceutical, Inc. On Thursday November 4, 2010, 11:19 am EDT
BOSTON, MA--(Marketwire - 11/04/10) - Spencer Pharmaceutical Inc. (Pinksheets:SPPH - News) announced today that it has received an all-cash offer from a private equity firm.
According to the company, a private equity firm has provided the board of directors with an all-cash offer to acquire any and all shares of the company. The board of directors has agreed to keep the offer confidential until an investment bank can be mandated to review the offer, conduct an appropriate due-diligence and recommend a course of action.
"We are surprised to be receiving an all-cash offer at this stage, and in order to keep our shareholders informed , we have opted to announce the receipt of the offer yet until we can have an independent review of the offer we will remain quiet as to his details," said Dr. Arella, President of Spencer Pharmaceutical Inc. "We don't want to alarm our shareholders and or put false hopes that a transaction is imminent so all we can do at this time is continue with the development of our licensing program and further development of our technology and business model to create sustainable shareholder value," further added Dr. Arella.
The final terms and conditions of the transaction will be determined in a definitive agreement. No assurances can be provided that a definitive agreement will be executed. Execution of a definitive agreement is subject to, among other things, confirming due diligence by Spencer, and other conditions and approvals by both companies' management, board of directors and shareholders, as appropriate.
About Spencer Pharmaceutical Inc.
Spencer Pharmaceutical Inc. is a US-based Pharmaceutical Research and Development Corporation, which is developing innovative drug release and absorption systems for the treatment of metabolic diseases such as diabetes and metabolic syndrome.
Important Information About Forward-Looking Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above. In addition, such statements could be affected by risks and uncertainties related to the exploration for and development of mineralized material, product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Company's website does not constitute a part of this release.
Contact:
Contact:
Dr. Max Arella
President
Spencer Pharmaceutical Inc.
Tel. 1+(617) 973-5017
HUGE SPPH NEWS
Spencer Pharmaceutical Receives Unsolicited All-Cash Offer
marketwire
*
Share
*
retweet
* Email
* Print
*
Companies:
o Spencer Pharmaceutical Inc.
Related Quotes
Symbol Price Change
SPPH.PK 0.2850 -0.0050
Chart for EMERGENSYS CORP
{"s" : "spph.pk","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00","o" : "","j" : ""}
Press Release Source: Spencer Pharmaceutical, Inc. On Thursday November 4, 2010, 11:19 am EDT
BOSTON, MA--(Marketwire - 11/04/10) - Spencer Pharmaceutical Inc. (Pinksheets:SPPH - News) announced today that it has received an all-cash offer from a private equity firm.
According to the company, a private equity firm has provided the board of directors with an all-cash offer to acquire any and all shares of the company. The board of directors has agreed to keep the offer confidential until an investment bank can be mandated to review the offer, conduct an appropriate due-diligence and recommend a course of action.
"We are surprised to be receiving an all-cash offer at this stage, and in order to keep our shareholders informed , we have opted to announce the receipt of the offer yet until we can have an independent review of the offer we will remain quiet as to his details," said Dr. Arella, President of Spencer Pharmaceutical Inc. "We don't want to alarm our shareholders and or put false hopes that a transaction is imminent so all we can do at this time is continue with the development of our licensing program and further development of our technology and business model to create sustainable shareholder value," further added Dr. Arella.
The final terms and conditions of the transaction will be determined in a definitive agreement. No assurances can be provided that a definitive agreement will be executed. Execution of a definitive agreement is subject to, among other things, confirming due diligence by Spencer, and other conditions and approvals by both companies' management, board of directors and shareholders, as appropriate.
About Spencer Pharmaceutical Inc.
Spencer Pharmaceutical Inc. is a US-based Pharmaceutical Research and Development Corporation, which is developing innovative drug release and absorption systems for the treatment of metabolic diseases such as diabetes and metabolic syndrome.
Important Information About Forward-Looking Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above. In addition, such statements could be affected by risks and uncertainties related to the exploration for and development of mineralized material, product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Company's website does not constitute a part of this release.
Contact:
Contact:
Dr. Max Arella
President
Spencer Pharmaceutical Inc.
Tel. 1+(617) 973-5017
SPPH-TONS OF NEWS TO REVIEW
http://www.spencerpharmaceutical.com/index.php?pg=quotes&cat=ir
SPPH-TONS OF NEWS TO REVIEW
http://www.spencerpharmaceutical.com/index.php?pg=quotes&cat=ir